affected each year
of all adults in US
deaths from suicide
patients who can’t take antidepressants
Major depressive disorder is a condition which lasts two or more weeks and interferes with a person’s ability to carry out daily tasks and enjoyed activities that previously brought pleasure. This condition affects approximately 16 million American adults, or about 6.7 percent of the U.S. population age 18 and older.1
The exact cause of depression is not known, but leading research in Neuroscience points to an imbalance in the brain’s neurotransmitters as the manifestation of depression. Neurotransmitters are chemical messengers that send signals between brain cells. A person’s genetic make-up and life history may also determine a person’s tendency to become depressed.
In 2016 a study conducted by the Center for Behavioral Health Statistics and Quality reported that major depressive disorder will affect approximately 16 million American adults (about 6.7% of the US population) in a given year. 1
Yes. The National Institute of Mental Health maintains that, “Depressive illness can often interfere with normal functioning and cause pain and suffering not only to those who have the disorder, but to those who care about them. Serious depression can destroy family life as well as the life of the ill person.” A national study of depression found that nearly all the respondents who reported a major depressive disorder also reported that their social and/or work lives were negatively affected by their illness.1 In 2010, the economic burden of depression was estimated at $210 billion in the US2 and depression was the second leading cause of disability, accounting for almost 20% of all years of life lost to disability and premature death.3 Depression can also be a lethal disease. Each year in the US, over 30,000 people die by suicide, 60% of whom suffer from depression.4, 5
There is no known cure for depression but with effective clinical depression psychotherapy, many patients can remain symptom free. Approaching an efficient depression treatment center like Sozo Centers is the right step towards your mental health treatment.
Spravato® has been FDA-approved since 2019 and evaluated in both short- and long-term trials for safety and efficacy.
SPRAVATO® is prescribed for those patients suffering from Treatment Resistant Depression (TRD). If you are currently diagnosed with clinical depression and have not responded well to at least two different oral anti-depressants, then SPRAVATO® may be right for you.
Before starting Spravato® therapy, we will discuss all potential side effects and interactions, and make sure Spravato® is right for you. While administering Spravato® in our wellness suites, patients will be monitored closely for any adverse side effects. Treatment Resistant Depression can be challenging for you to deal with but with support from an efficient mental health provider, you can bring a change in your life. Sozo Centers is one of the best depression treatment centers and our dedicated wellness staff strives the best for your mental wellbeing.